Edition:
United States

Profile: Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

212.50GBp
21 Jul 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
212.50p
Open
212.50p
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,666
52-wk High
270.00p
52-wk Low
78.75p

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Company Address

Akers Biosciences Inc

201 Grove Rd
WEST DEPTFORD   NJ   08086-2231
P: +1856.8488698

Company Web Links